Skip to Main Content

Paper Details

PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
JCI Insight
31
2019
ADP, ADP-ribose-acceptor hydrolase 3, AIF, ARH3, ARH3 deficiency, ARH3 gene, ARH3 gene mutation, H2O2, PAR, PARG, PARP1, Poly(ADP-ribose), Poly(ADP-ribose) polymerase 1, Poly(ADP-ribosyl), apoptosis-inducing factor, cerebral ischemia/reperfusion, fibroblasts, human, human cells, hydrogen peroxide, ischemia, mice, neurodegeneration, neurons, nuclear PAR, parthanatos, patient, patients, poly(ADP-ribose), poly(ADP-ribose) glycohydrolase, ribose
Author NameAffiliation
Lynne A Wolfe
Lynne A Wolfe
Camilo Toro
David R Adams
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute
David R Adams
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute
Thomas C Markello
William A Gahl
William A GahlOffice of the Clinical Director, National Human Genome Research Institute
William A Gahl
William A GahlOffice of the Clinical Director, National Human Genome Research Institute
  • 1 - 12

Datasets

Release 1.2